Unknown

Dataset Information

0

Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.


ABSTRACT: Oligodendrocytes, which are the main cell type in cerebral white matter, are generated from their precursor cells (oligodendrocyte precursor cells: OPCs). However, the differentiation from OPCs to oligodendrocytes is disturbed under stressed conditions. Therefore, drugs that can improve oligodendrocyte regeneration may be effective for white matter-related diseases. Here we show that a vasoactive peptide adrenomedullin (AM) promotes the in vitro differentiation of OPCs under pathological conditions. Primary OPCs were prepared from neonatal rat brains, and differentiated into myelin-basic-protein expressing oligodendrocytes over time. This in vitro OPC differentiation was inhibited by prolonged chemical hypoxic stress induced by non-lethal CoCl(2) treatment. However, AM promoted the OPC differentiation under the hypoxic stress conditions, and the AM receptor antagonist AM(22-52) canceled the AM-induced OPC differentiation. In addition, AM treatment increased the phosphorylation level of Akt in OPC cultures, and correspondingly, the PI3K/Akt inhibitor LY294002 blocked the AM-induced OPC differentiation. Taken together, AM treatment rescued OPC maturation under pathological conditions via an AM-receptor-PI3K/Akt pathway. Oligodendrocytes play critical roles in white matter by forming myelin sheath. Therefore, AM signaling may be a promising therapeutic target to boost oligodendrocyte regeneration in CNS disorders.

SUBMITTER: Maki T 

PROVIDER: S-EPMC4516627 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4681621 | BioStudies
1000-01-01 | S-EPMC5919806 | BioStudies
2013-01-01 | S-EPMC3985753 | BioStudies
2019-01-01 | S-EPMC6715717 | BioStudies
2014-01-01 | S-EPMC4096908 | BioStudies
2018-01-01 | S-EPMC6763517 | BioStudies
2020-01-01 | S-EPMC7026842 | BioStudies
2018-01-01 | S-EPMC5918158 | BioStudies
2019-01-01 | S-EPMC6573028 | BioStudies
2018-01-01 | S-EPMC5856724 | BioStudies